The value of multimodal ultrasound imaging in differentiating HER2-positive breast cancer
Multimodal ultrasound parameters from CUS, CEUS, and SRUS can predict HER2-positive breast cancer, and their combination provides superior diagnostic efficacy.
Authors
- Hua-Rong Ye (ORCID: https://orcid.org/0000-0003-2313-6755)
- Bing-Song Lei
- Chen Liu (ORCID: https://orcid.org/0009-0003-0430-6146)
- Qijun Wang (ORCID: https://orcid.org/0000-0002-4299-3798)
- S. Q. Zeng
- Yu-Meng Lei
- Chen Liao
- Ge Zhang
Institutions
- Hubei Cancer Hospital (CN)
- Wuhan University of Science and Technology (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.3389/fonc.2026.1718785
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wuhan University
- Wuhan University of Science and Technology